All stock lists
CONMED Corp (New York Stock Exchange:CNMD)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
51.50-1.33 (-2.52%)
Market cap
$1.53B
Insider Score
Health Score
Analyst consensus
Listed since
Jul 23, 1987
Website
Insider Score
––Not scored
CNMD Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CNMD analyst forecast
CNMD analyst consensus
Hold2 ratings
Buy 0 Hold 2 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CNMD 12-month price target
No published price targets in the last 12 months.
CNMD ratings mix, last 12 months
Buy Hold Sell
Best analysts covering CNMD
No firm covering CNMD has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CNMD analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-10-29 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-10-29 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-07-30 |
| — | Piper Sandler | Neutral | — | — | Reiterated | 2026-07-30 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2026-06-29 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-05-18 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-05-01 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-04-30 |
| — | Piper Sandler | Neutral | — | — | Downgraded | 2026-03-17 |
| — | Needham | Hold | — | — | Reiterated | 2026-01-29 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-01-29 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2025-12-08 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-11-06 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-11-06 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-11-06 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2025-07-31 |
| — | Needham | Hold | — | — | Downgraded | 2025-06-12 |
| — | Needham | Buy | — | — | Reiterated | 2025-05-01 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-05-01 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-05-01 |
| — | Stifel | Hold | — | — | Downgraded | 2025-04-28 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2025-02-06 |
| — | Needham | Buy | — | — | Reiterated | 2025-02-06 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-02-06 |
| — | Stifel | Buy | — | — | Reiterated | 2025-02-06 |
| — | Needham | Buy | — | — | Reiterated | 2024-10-31 |
| — | Needham | Buy | — | — | Reiterated | 2024-10-04 |
| — | Needham | Buy | — | — | Reiterated | 2024-08-01 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-08-01 |
| — | Stifel | Buy | — | — | Reiterated | 2024-08-01 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2024-08-01 |
| — | Needham | Buy | — | — | Reiterated | 2024-07-25 |
| — | Needham | Buy | — | — | Reiterated | 2024-05-06 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2024-04-25 |
| — | Needham | Buy | — | — | Reiterated | 2024-04-25 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-04-25 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-04-25 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-02-01 |
| — | Needham | Buy | — | — | Reiterated | 2024-02-01 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2024-02-01 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2024-02-01 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-10-27 |
| — | Stifel | Buy | — | — | Reiterated | 2023-10-26 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2023-10-26 |
| — | Needham | Buy | — | — | Reiterated | 2023-10-26 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2023-07-27 |
| — | Needham | Buy | — | — | Reiterated | 2023-07-27 |
| — | Keybanc | Overweight | — | — | Reiterated | 2023-07-27 |
| — | Needham | Buy | — | — | Reiterated | 2023-07-24 |
| — | Needham | Buy | — | — | Reiterated | 2023-06-05 |
| — | CL King | Buy | — | — | Reiterated | 2023-05-22 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2023-04-27 |
| — | Keybanc | Overweight | — | — | Reiterated | 2023-04-27 |
| — | Needham | Buy | — | — | Reiterated | 2023-04-27 |
| — | Stifel | Buy | — | — | Reiterated | 2023-04-27 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-04-27 |
| — | Keybanc | Overweight | — | — | Upgraded | 2023-03-27 |
| — | Piper Sandler | Overweight | — | — | Reiterated | 2023-02-03 |
| — | Needham | Buy | — | — | Reiterated | 2023-02-03 |
| — | Needham | Buy | — | — | Reiterated | 2022-11-15 |
CNMD earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-01-28 | 1.32 | 1.43 | $366.9M | $373.2M |
| 2026-04-29 | 0.82 | 0.89 | $310.6M | $317.0M |
| 2026-07-29 | 1.11 | 1.38 | $337.6M | $343.5M |
| 2026-10-28 | 1.00 | 1.04 | $336.3M | $335.6M |
| 2027-01-27Upcoming | 1.27 | — | $366.6M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.